Abstract:Background and objective: Aortic blood pressure (ABP) is a more effective prognostic indicator of cardiovascular disease than peripheral blood pressure. A highly accurate algorithm for non-invasively deriving the ABP wave, based on ultrasonic measurement of aortic flow combined with peripheral pulse wave measurements, has been proposed elsewhere. However, it has remained at the proof-of-concept stage because it requires a priori knowledge of the ABP waveform to calculate aortic pulse wave velocity (PWV). The objective of this study is to transform this proof-of-concept algorithm into a clinically feasible technique. Methods: We used the Bramwell-Hill equation to non-invasively calculate aortic PWV which was then used to reconstruct the ABP waveform from non-invasively determined aortic blood flow velocity, aortic diameter, and radial pressure. The two aortic variables were acquired by an ultrasound system from 90 subjects, followed by recordings of radial pressure using a SphygmoCor device. The ABPs estimated by the new algorithm were compared with reference values obtained by cardiac catheterization (invasive validation, 8 subjects aged 62.3 ± 12.7 years) and a SphygmoCor device (non-invasive validation, 82 subjects aged 45.0 ± 17.8 years). Results: In the invasive comparison, there was good agreement between the estimated and directly measured pressures: the mean error in systolic blood pressure (SBP) was 1.4 ± 0.8 mmHg; diastolic blood pressure (DBP), 0.9 ± 0.8 mmHg; mean blood pressure (MBP), 1.8 ± 1.2 mmHg and pulse pressure (PP), 1.4 ± 1.1 mmHg. In the non-invasive comparison, the estimated and directly measured pressures also agreed well: the errors being: SBP, 2.0 ± 1.4 mmHg; DBP, 0.8 ± 0.1 mmHg; MBP, 0.1 ± 0.1 mmHg and PP, 2.3 ± 1.6 mmHg. The significance of the differences in mean errors between calculated and reference values for SBP, DBP, MBP and PP were assessed by paired t-tests. The agreement between the reference methods and those obtained by applying the new approach was also expressed by correlation and Bland-Altman plots. Conclusion: The new method proposed here can accurately estimate ABP, allowing this important variable to be obtained non-invasively, using standard, well validated measurement techniques. It thus has the potential to relocate ABP estimation from a research environment to more routine use in the cardiac clinic. Short abstract: A highly accurate algorithm for non-invasively deriving the ABP wave has been proposed elsewhere. However, it has remained at the proof-of-concept stage because it requires a priori knowledge of the ABP waveform to calculate aortic pulse wave velocity (PWV). This study aims to transform this proof-of-concept algorithm into a clinically feasible technique. We used the Bramwell-Hill equation to non-invasively calculate aortic PWV which was then used to reconstruct the ABP waveform. The ABPs estimated by the new algorithm were compared with reference values obtained by cardiac catheterization or a SphygmoCor device. The results showed that there was good agreement between the estimated and directly measured pressures. The new method proposed can accurately estimate ABP, allowing this important variable to be obtained non-invasively, using standard, well validated measurement techniques. It thus has the potential to relocate ABP estimation from a research environment to more routine use in the cardiac clinic.

In silico modelling of stroke volume, cardiac output and systemic vascular resistance in cardiovascular safety pharmacology studies by telemetry

A Simple Blood Microdialysis in Freely-Moving Rats for Pharmacokinetic–pharmacodynamic Modeling Study of Shengmai Injection with Simultaneous Determination of Drug Concentrations and Efficacy Levels in Dialysate

A novel cardiovascular systems model to quantify drugs effects on the inter‐relationship between contractility and other hemodynamic variables

Testing a patient-specific in-silico model to noninvasively estimate central blood pressure

Leveraging Cardiovascular Simulations for In-Vivo Prediction of Cardiac Biomarkers

Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction

Evaluation of the translation of multiple cardiovascular regulatory mechanisms in the anesthetized dog

Combined in silico model of cardiac electrophysiological activity and modulation by the autonomic nervous system

Simulation-based Inference for Cardiovascular Models

[In vivo integrated safety assessment of the cardiovascular system in drug development]

In-vitro Major Arterial Cardiovascular Simulator to generate Benchmark Data Sets for in-silico Model Validation

Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose

Inferring the Frank–Starling Curve From Simultaneous Venous and Arterial Doppler: Measurements From a Wireless, Wearable Ultrasound Patch

Validation of a New Method for Stroke Volume Variation Assessment: a Comparaison with the PiCCO Technique

Non-invasive in silico determination of ventricular wall pre-straining and characteristic cavity pressures

In Silico Human Cardiomyocyte Action Potential Modeling: Exploring Ion Channel Input Combinations

The virtual assay software for human in silico drug trials to augment drug cardiac testing

Two Useful Methods for Evaluating Antihypertensive Drugs in Conscious Freely Moving Rats.

Computer modelling and artificial intelligence with big data for better diagnostics and therapy of cardiovascular disease

Integration of Patient-specific Computational Hemodynamics and Vessel Wall Shear Stress Into MRI Diagnosis of Vascular Diseases

Patient-specific non-invasive estimation of the aortic blood pressure waveform by ultrasound and tonometry